NEW YORK (GenomeWeb) – Oregon Health & Science University (OHSU) and Swedish diagnostics firm Immunovia today announced a collaboration on a diagnostic test for the early detection of pancreatic cancer.

Under the terms of the agreement, the partners will confirm, validate, and commercialize the Immray PanCan-d blood test. A retrospective study using patients samples from OHSU's Brenden-Colson Center for Pancreatic Care will seek to confirm earlier results from studies in Europe and China with a US population. The partners will also explore biomarkers for other cancer types.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.